Jump to content

Tazarotene

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 79.121.106.220 (talk) at 12:20, 21 December 2008 (corrected IUPAC name). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Tazarotene
Clinical data
Pregnancy
category
Routes of
administration
Topical
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Protein binding>99%
Elimination half-life19 Hours
Identifiers
  • ethyl 6-[2-(4,4-dimethyl-3,4-dihydro-2H-1-benzothiopyran-6-yl)ethynyl]pyridine-3-carboxylate
CAS Number
PubChem CID
DrugBank
CompTox Dashboard (EPA)
ECHA InfoCard100.115.380 Edit this at Wikidata
Chemical and physical data
FormulaC21H21NO2S
Molar mass351.463 g/mol g·mol−1

Tazarotene (marketed as Tazorac, Avage and Zorac) is a prescription topical retinoid sold as a cream or gel. This medication is approved for treatment of psoriasis, acne, and sun damaged skin (photodamage). It is commonly sold in two concentrations: 0.05% and 0.1%.

Common side effects include worsening of acne, dry skin, itchiness, redness and in some cases extreme drying and cracking of skin. For most patients these side effects are uncomfortable but mild and decrease markedly after the first 2–4 weeks of use.

For best results dermatologists recommend applying the cream or gel once daily before bedtime after washing the face with a mild cleanser. Dermatologists recommend using a moisturizer with tazarotene so skin will not be as dry and flaky.

"There is limited evidence that tazarotene and isotretinoin benefit patients with moderate photodamage on the face: both are associated with skin irritation and erythema." [1]

In addition to tretinoin, which has been associated with greater skin improvements with high concentrations, tazarotene and isotretinoin creams are also found to be effective for photodamage, but at the expense of skin irritation. More evidence is needed before any recommendations can be made on oral or topical polysaccharides or hydroxy acids. Evidence from one trial suggests that the effectiveness of 0.05% tretinoin, is equivalent to the effects of 0.05% and 0.1% tazarotene.[1]

Notes

  1. ^ a b Samuel M, Brooke RC, Hollis S, Griffiths CE (2005). "Interventions for photodamaged skin". Cochrane Database Syst Rev (1): CD001782. doi:10.1002/14651858.CD001782.pub2. PMID 15674885.{{cite journal}}: CS1 maint: multiple names: authors list (link)